Skip to main content

Table 1 Baseline characteristics of study population stratified in pacemaker (PM) and non pacemaker group (N-PM)

From: Predictive factors for pacemaker requirement after transcatheter aortic valve implantation

 

PM (n=23)

N-PM (n=22)

p

Clinical parameters

Male, n (%)

10 (43.5)

8 (36.4)

0.763

Age (yrs)

80.7 ± 5.94

81.55 ± 7.90

0.684

Body mass index (kg/m2)

26.9 ± 3.9

26.8 ± 4.0

0.883

Hypertension, n (%)

22 (95.7)

19 (86.4)

0.346

Smoker, n (%)

8 (34.8)

4 (18.2)

0.024

Diabetes mellitus, n (%)

10 (43.5)

7 (31.8)

0.542

Creatinine (μmol/l)

151.2 ± 157.4

114.3 ± 51.6

0.372

Renal insufficiency (creatinine level > 1.5mg/dl), n (%)

14 (60.9)

11 (50)

0.554

Chronic obstructive pulmonary disease, n (%)

4 (17.1)

4 (18.2)

0.855

New York Heart Association functional class

I

0 (0)

0 (0)

0.263

II

0 (0)

2 (9.1)

 

III

15 (65.2)

15 (68.2)

 

IV

8 (34.8)

5 (22.7)

 

Logistic EuroSCORE (%)

24.0 ± 14.6

18.4 ± 19.2

0.034

Dyspnoe, n (%)

13 (56.6)

12 (54.6)

0.628

Angina, n (%)

11 (47.5)

6 (27.3)

0.022

Syncope, n (%)

3 (13.0)

8 (36.4)

0.091

Pulmonal artery pressure (mmHg)

42.8 ± 17.7

37.6 ± 19.9

0.375

Porcelain aorta, n (%)

1 (4.3)

3 (13.6)

0.346

Prior cardiac decompensation, n (%)

13 (56.5)

14 (63.7)

0.763

Ischemic heart disease, n (%)

20 (87.0)

15 (68.2)

0.017

Previous stroke, n (%)

10 (43.5)

3 (13.6)

0.047

Previous CABG, n (%)

1 (4.3)

2 (9.1)

0.838

Peripheral vessel disease, n (%)

5 (21.7)

1 (4.6)

0.002

Echocardiographic parameters

Mean aortic valve area (cm2)

0.8 ± 0.2

0.7 ± 0.2

0.108

Left ventricular ejection fraction (%)

46.1 ± 10.7

50.2 ± 12.5

0.224

Peak pressure gradient (mmHg)

90.6 ± 24.1

86.6 ± 27.9

0.641

Mean pressure gradient (mmHg)

57.7 ± 15.3

55.4 ± 15.6

0.674

Aortic annulus dimension (mm)

23.30 ± 5.32

22.36 ± 6.85

0.141

Aortic bulbus dimension (mm)

29.70 ± 5.86

28.61 ± 7.46

0.893

Interventricular septal dimension (mm)

14.17 ± 3.82

13.55 ± 2.46

0.627

Aortic regurgitation grade ≥ I, n (%)

19 (82.6)

20 (90.9)

0.692

Mitral insufficiency ≥ grade I, n (%)

22 (95.7)

19 (86.4)

0.247